Capitalizing Life Science Innovations

  prolor biotech

Shai Novik, Former Chief Executive Officer

Prolor Biotech, Inc. - Acquired by OPKO Health, Inc. (NASDAQ: OPK) in 2013

"Menachem shared our vision and believed in our team pre Proof of Concept. He identified our risk mitigated scientific strategy of developing proprietary versions of already approved therapeutic proteins, extending their lifespan without additional toxicity or loss of desired biological activity. He invested his own capital and used his network to become a champion of our company."